Intracellular pool of IL-10 receptors in specific granules of human neutrophils: differential mobilization by proinflammatory mediators.
IL-10 has a wide range of effects tending to control inflammatory responses. We used flow cytometry to study IL-10 binding at the polymorphonuclear neutrophil (PMN) surface and its modulation by various proinflammatory agents. Little IL-10 bound to the surface of resting PMN. However, binding was strongly increased after stimulation with LPS and proinflammatory cytokines such as TNF and GM-CSF. IL-1 and IL-8 did not significantly modify IL-10 binding. Cycloheximide had no effect on TNF-induced IL-10 binding, strongly suggesting the release of a pre-existing pool of IL-10R rather than de novo receptor synthesis by PMN. This was confirmed by the inhibitory effect of pentoxifylline, an inhibitor of degranulation. The existence of an intracellular pool of IL-10R was shown by flow cytometry, immunocytochemical staining, and Western blotting with several anti-human IL-10R Abs. In subcellular fractions of resting PMN, IL-10R was mainly located in the specific granule fraction, and was absent from azurophil granules and cytosol. We also tested the mobilization of specific granules by measuring the release of lactoferrin, their reference marker. The differential effects of the proinflammatory agents on IL-10 binding matched their effects on lactoferrin release and may therefore be related to differential mobilization of specific granules by these agents. Furthermore, the kinetics of TNF-induced up-regulation of IL-10 binding to PMN ran parallel to the kinetics of the inhibitory effect of IL-10 on the oxidative burst, suggesting a key role of IL-10R mobilization from specific granules to the membranes in optimal regulation of inflammatory responses.
Elbim
C
C
Institut National de la Santé et de la Recherche Médicale Unité 479 and Service d'Immunologie et d'Hématologie, Paris, France.
Reglier
H
H
Fay
M
M
Delarche
C
C
Andrieu
V
V
El Benna
J
J
Gougerot-Pocidalo
M A
MA
D015550:Cell Degranulation / Q000187:drug effects / Q000276:immunology; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism; D003594:Cytoplasmic Granules / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism*; D018093:Gelatinases / Q000032:analysis; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology*; D007399:Interphase / Q000276:immunology; D007424:Intracellular Fluid / Q000276:immunology* / Q000378:metabolism*; D007781:Lactoferrin / Q000378:metabolism; D009504:Neutrophils / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism*; D010431:Pentoxifylline / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects / Q000276:immunology; D018123:Receptors, Interleukin / Q000378:metabolism*; D053701:Receptors, Interleukin-10; D016897:Respiratory Burst / Q000276:immunology; D013347:Subcellular Fractions / Q000276:immunology / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology; D015854:Up-Regulation / Q000187:drug effects / Q000276:immunology
D018836:Inflammation Mediators; D018123:Receptors, Interleukin; D053701:Receptors, Interleukin-10; D014409:Tumor Necrosis Factor-alpha; D013481:Superoxides; D007781:Lactoferrin; D018093:Gelatinases; D010431:Pentoxifylline